NCT00101374View on ClinicalTrials.gov

Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 5, 2005

Primary Completion Date

May 21, 2008

Study Completion Date

May 21, 2008

Conditions
HIV Infections
Interventions
DRUG

Leflunomide

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00101374 - Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients | Biotech Hunter | Biotech Hunter